The first half of 2020 has been defined by the outbreak of COVID-19. And with the coronavirus pandemic likely to continue to cast a long shadow, uncertainties within the off-patent industry and medicines sector as a whole persist.
Accord Healthcare has been among those firms at the heart of European efforts to fight the pandemic through concerted generics...




